Surgical Techniques for Mouse Heart Transplantation

Author(s):  
Z. K. Chen ◽  
S. Metcalfe
Author(s):  
Decheng Yin ◽  
Jian Fu ◽  
Ida Allabauer ◽  
Oliver Witzke ◽  
Song Rong ◽  
...  

Author(s):  
Ayyaz Ali ◽  
Robert L. Kormos

Cardiac transplantation has extended and improved the lives of patients suffering from severe heart failure over many decades. Despite advances in medical therapy, cardiac transplantation remains the definitive treatment for end-stage heart disease. Surgical techniques for organ procurement and implantation, development of appropriate methods for preserving the heart, and understanding the immunological challenges associated with transplantation were among the many areas which required focused investigation. In the current era, heart transplantation is associated with a low operative mortality and excellent long-term survival, however, the major obstacle of shortage of suitable donor organs remains. In the following chapter, recipient selection and management, donor organ procurement and preservation, and surgical techniques of heart transplantation are described in detail.


2020 ◽  
Vol 61 (3) ◽  
pp. 595-600
Author(s):  
Jiali Wu ◽  
Xiangdong Liu ◽  
Maohua Wang ◽  
Xiaobin Wang ◽  
De Luo ◽  
...  

Microsurgery ◽  
2006 ◽  
Vol 26 (8) ◽  
pp. 594-598 ◽  
Author(s):  
Kun Wu ◽  
Jinyan Zhang ◽  
Jian Fu ◽  
Shengli Wu ◽  
Thomas Philipp ◽  
...  

2019 ◽  
Vol 104 (12) ◽  
pp. 1216-1222
Author(s):  
Zdenka Reinhardt

Heart transplantation is a standard treatment for selected paediatric patients with end-stage heart disease. With improvement in surgical techniques, organ procurement and preservation strategies, immunosuppressive drugs, and more sophisticated monitoring strategies, survival following transplantation has increased over time. However, rejection, infection, renal failure, post-transplant lymphoproliferative disease and post-transplant cardiac allograft vasculopathy still preclude long-term survival. Therefore, continued multidisciplinary scientific efforts are needed for future gains. This review focuses on the current status, outcomes and ongoing challenges including patient selection, indications and contraindications, national and international survivals, post-transplant complications and quality of life.


2016 ◽  
Vol 119 (suppl_1) ◽  
Author(s):  
Manuel Rosa-Garrido ◽  
Todd Kimball ◽  
Douglas J Chapski ◽  
Tsai-Ting Shih ◽  
Elizabeth Soehalim ◽  
...  

Heart failure is a syndrome resulting from complex genetic predisposition and multiple environmental factors. It is well established that global changes in gene expression accompany the transition through hypertrophy and on to overt failure producing deterioration of function at the organ level. Unknown, however, are the global changes in chromatin structure that allows for pathological gene expression. The epigenetic factor CTCF is a ubiquitous protein thought to be involved in maintenance of chromatin microenvironments. We found that hypertrophic stimulation down-regulates CTCF in the heart, and CTCF expression is significantly correlated with heart size in disease across genetic backgrounds. To test this relationship further, we have generated an inducible cardiac-specific CTCF knockout animal. These animals quickly develop severe heart failure characterized by a dilated left ventricle, decreased ejection fraction, and reactivation of the fetal gene program. Our analysis of published CTCF ChIP-seq data performed in mouse heart has also shown CTCF binding peaks flanking the fetal genes. Furthermore, we have found that CTCF abundance at these sites changes after hypertrophic agonist isoproterenol treatment, suggesting that CTCF protects from the development of cardiac disease by regulating gene expression. We also used RNA-seq to compare the transcriptome of adult myocytes isolated from control, CTCF KO mice, and mice that underwent transverse aortic constriction (TAC) to induce heart failure. These analyses showed that CTCF depletion remodels gene expression in a manner that mimics aspects of the pathological transcriptome in heart failure. Our data demonstrate that precise control of CTCF levels is required for normal transcriptome regulation in the adult heart and that alterations in CTCF levels (either via genetic, pharmacologic or surgical techniques) lead to cardiac pathology.


Author(s):  
Ahmed El-Eshmawi ◽  
Anelechi Anyanwu

Orthotopic heart transplantation (OHT) has evolved as the “gold standard” therapy for end stage cardiomyopathy, Advances in the fields of immunosuppression, infection prophylaxis and treatment, surgical techniques as well as intensice care management have transformed heart transplantation from what was once considered an experimental intervention into a standard therapy. This chapter focuses on the standard care for OHT including surgical techniques, perioperative management and management of common postoperative complications.


Sign in / Sign up

Export Citation Format

Share Document